Case Report Volume 3 Issue 1 - 2025

Epidermoid Cyst of the CPA with Suprasellar and IAC Extension: A Case of Mass Effect Without Malignancy

Zineb Labbi*, Beqqali Basma, Zaynab Iraqi Houssaini, Ola Messaoud, El Aoufir Omar and Jrondi Laila

Department of Emergency Radiology, Faculty of Medicine, Ibn Sina University Hospital, Rabat, Morocco

*Corresponding Author: Zineb Labbi, Department of Emergency Radiology, Faculty of Medicine, Ibn Sina University Hospital, Rabat, Morocco.
Received: October 01, 2025; Published: November 11, 2025



Background: Epidermoid cysts are congenital, benign lesions most commonly located in the cerebellopontine angle (CPA) and parasellar cisterns. They typically show restricted diffusion on MRI without contrast enhancement, a feature that often confirms the diagnosis. However, in some cases, they may exert significant mass effect that mimics low-grade or cystic tumors.

Case Report: We present the case of a 34-year-old man who experienced a first-time generalized seizure. MRI revealed a non-enhancing lesion in the left CPA and suprasellar cistern that showed bright diffusion restriction, consistent with an epidermoid cyst. The lesion displaced nearby brain structures-including the temporal lobe, pons, and posterior cerebral artery-yet did not cause edema or enhancement. A complete imaging work-up, including DWI, T1, T2, fat-suppressed, and susceptibility sequences, confidently excluded neoplastic or dermoid pathology.

Conclusion: Even when epidermoid cysts cause mass effect, their lack of enhancement and absence of edema are distinguishing features that separate them from tumors. Careful use of multi-sequence MRI is essential in evaluating these lesions and can help avoid unnecessary intervention while guiding appropriate surgical planning [1,2,3,6].

 Keywords: Epidermoid Cyst; Cerebellopontine Angle; Diffusion-Weighted Imaging; Tumor Mimic; Suprasellar Cistern; Internal Auditory Canal

Zineb Labbi., et al. “Epidermoid Cyst of the CPA with Suprasellar and IAC Extension: A Case of Mass Effect Without Malignancy”. EC Cancer  3.1 (2025): 01-04.